NYSE CRTR Economy Event Watch the replay →

Advertisement
Advertisement
Segment| Data as of 06/11/2026
trending up

Tomorrow's Treatments ETFs

1D perf
2.61%
1D flows
+$2M
Total AuM
$572M
Total ETFs
91 new

Aggregate data of 9 funds

Performance

-5.0-4.0-3.0-2.0-1.00.01.0%May 11May 18May 25Jun 1Jun 8

Flows

0 M2 M4 M6 M8 M
1M3MYTD1Y3Y5Y
Perf.-2.04%-0.36%+3.34%+45.36%+46.09%
Flows+$6M+$48M+$122M+$144M+$269M-

Top ETFs in this segment

1D+2.35%1W flows+$4MView
1D+2.14%1W flows+$2MView
1D+1.3%1W flows+$344KView
Advertisement

Just published in Tomorrow's Treatments

View all articles

Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities

Small-cap biotech ETFs focus on early-stage companies, offering explosive upside potential but higher risks compared to market-cap weighted competitors.

Biotech etfs

Movers in Tomorrow's Treatments

Top
Bottom
Top performers, 1 week1W perf.YTD perf.
ASD
Defiance Autism Impact ETF+0.80% 
MEDX
Horizon Kinetics Medical ETF+0.51%+4.37%
BBP
Virtus LifeSci Biotech Products ETF+0.42%+8.85%
CANC
Tema Oncology ETF+0.33%+7.46%
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF+0.09%-2.68%
Top inflows, 1 week1W flowYTD flows
CANC
Tema Oncology ETF+$4M+$51M
OZEM
Roundhill GLP-1 & Weight Loss ETF+$2M+$12M
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF+$344K-$1M
BBP
Virtus LifeSci Biotech Products ETF-+$30M
ASD
Defiance Autism Impact ETF--

Data period: June 4 - 11, 2026

Performance lists exclude leveraged and inverse ETFs

Recently launched ETFs

Inception
ASD
Defiance Autism Impact ETF1/21/1970

Related indexes by ICE

NYFSGIB
NYSE FactSet Global Genomics and Immuno Biopharma IndexView on ICE
NYFSNBM
NYSE FactSet Global Neuro Biopharma and MedTech IndexView on ICE

Latest news about Thematic Investing: Tomorrow's Treatments

Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities

Small-cap biotech ETFs focus on early-stage companies, offering explosive upside potential but higher risks compared to market-cap weighted competitors.

Biotech etfs

Obesity and Weight-Loss Drugs: A New Thematic ETF Segment?

The ongoing Ozempic and weight-loss drug obsession has investors and ETF issuers turning to new ways of gaining healthcare sector exposure.

Weight-loss-drugs

Two biotech ETFs to watch for the rest of 2022 and beyond

Investors with a high tolerance for risk may seek to gain exposure to the growth potential of the biotech industry. We take a look at two ETFs that have rallied over the last month.

Two biotech ETFs to watch for the rest of 2022 and beyond
Advertisement
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides

Recent educational content

The ETF Show - New Autism-Impact ETF Launched

Asset TV

The ETF Show - New Autism-Impact ETF Launched

Defiance ETFs has launched the first ETF, $ASD, focused on the autism ecosystem, investing in companies that provide services, products, and research related to autism and neurodivergence.

Asset TV
By Asset TV · June 4, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs June 1, 2026

The ETF Industry saw 22 New Launches, 1 Ticker Change and 1 closure last week.

Tidal
By Tidal · June 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs May 20, 2026

The ETF Industry saw 44 New Launches, 3 Mutual Fund Conversions and 9 closures last week.

Tidal
By Tidal · May 19, 2026
The ETF Show - Politics Becomes Investable Trade through ETFs

Asset TV

The ETF Show - Politics Becomes Investable Trade through ETFs

Dan Weiskopf, Senior Portfolio Manager at Tidal Financial Group spoke with the ETF Show about Subversive ETFs that help investors trade like politicians.

Asset TV
By Asset TV · May 18, 2026

Browse all educational columns

The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up